Neon Therapeutics, Inc.
Neon is a Massachusetts-based biopharmaceutical company that develops and commercializes neoantigen-targeted therapies for the treatment of cancer.
Business Model:
Revenue: $1M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Neon Therapeutics, Inc. Information
Neon Therapeutics, Inc. was acquired by
BioNTech.
The acquisition happend on 2020-01-16.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 40 Erie Street
City: Cambridge
State: MA
Zip: 02139
Country: US
Financial Info
Stage:
series b
Raised Last:
$36M
Raised Total:$161M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Neon is a Massachusetts-based biopharmaceutical company that develops and commercializes neoantigen-targeted therapies for the treatment of cancer.
Contact Phone:
+16173374701
Contact Email:
Neon Therapeutics, Inc. went public on 6/26/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/26/2018
IPO Valuation:
$451M
Ticker Symbol:
NTGN
IPO Price:
$16/share
Amount Raised:
$100M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2017 | Series B | 7 | $70M |
Partner Fund Management Partner Fund Management Access Industries Fidelity Management and Research Company Inbio Ventures Nextech Invest Third Rock Ventures Wellington Management Partner Fund Management Partner Fund Management |
10/2015 | Series A | 3 | $55M |
Third Rock Ventures Clal Biotechnology Industries Access Industries Third Rock Ventures |
12/2017 | Series B | 9 | $36M |
Hillhouse Capital Group ArrowMark Partners Casdin Capital Nextech Invest Access Industries Wellington Management Inbio Ventures Partner Fund Management Fidelity Management and Research Company Hillhouse Capital Group ArrowMark Partners Casdin Capital Nextech Invest Access Industries Wellington Management Inbio Ventures Partner Fund Management Fidelity Management and Research Company |
6/2018 | IPO | $100M | 9/2015 | Series A | $55M |
Third Rock Ventures, LLC Access Industries Clal Biotechnology Industries |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
